产品标题 产品货号 产品规格 厂家
N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 5 from ORIGENE TECHNOLOGIESLY424588100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 6 from ORIGENE TECHNOLOGIESLY431840100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 7 from ORIGENE TECHNOLOGIESLY431309100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1), transcript variant 9 from ORIGENE TECHNOLOGIESLY431835100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene) (NAT8B) from ORIGENE TECHNOLOGIESLY402542100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 6 (GCN5-related) (NAT6) from ORIGENE TECHNOLOGIESLY415920100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 10 (GCN5-related) (NAT10), transcript variant 1 from ORIGENE TECHNOLOGIESLY411178100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 8 (GCN5-related, putative) (NAT8) from ORIGENE TECHNOLOGIESLY401303100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 1 from ORIGENE TECHNOLOGIESLY421227100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 9 (GCN5-related, putative) (NAT9) from ORIGENE TECHNOLOGIESLY414415100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 1 from ORIGENE TECHNOLOGIESLY425958100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 3 from ORIGENE TECHNOLOGIESLY421226100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 2 from ORIGENE TECHNOLOGIESLY411017100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 15 (GCN5-related, putative) (NAT15), transcript variant 3 from ORIGENE TECHNOLOGIESLY425957100 ugORIGENE TECHNOLOGIES
N-acetyltransferase 8-like (GCN5-related, putative) (NAT8L) from ORIGENE TECHNOLOGIESLY403615100 ugORIGENE TECHNOLOGIES
Human dihydropyrimidinase-like 4 (DPYSL4) from ORIGENE TECHNOLOGIESTP31482120 ugORIGENE TECHNOLOGIES
Human dihydropyrimidinase-like 5 (DPYSL5) from ORIGENE TECHNOLOGIESTP30263120 ugORIGENE TECHNOLOGIES
Human dihydropyrimidinase-like 2 (DPYSL2) from ORIGENE TECHNOLOGIESTP30908020 ugORIGENE TECHNOLOGIES
Human dihydropyrimidine dehydrogenase (DPYD) from ORIGENE TECHNOLOGIESTP31637420 ugORIGENE TECHNOLOGIES
Human dihydrouridine synthase 1-like (S. cerevisiae) (DUS1L) from ORIGENE TECHNOLOGIESTP30901520 ugORIGENE TECHNOLOGIES
Human dihydrouridine synthase 3-like (S. cerevisiae) (DUS3L) from ORIGENE TECHNOLOGIESTP30338020 ugORIGENE TECHNOLOGIES
Human dihydrouridine synthase 4-like (S. cerevisiae) (DUS4L), full length from ORIGENE TECHNOLOGIESTP76097050 ugORIGENE TECHNOLOGIES
Human dihydrouridine synthase 2-like, SMM1 homolog (S. cerevisiae) (DUS2L) from ORIGENE TECHNOLOGIESTP30017520 ugORIGENE TECHNOLOGIES
Human dihydroxyacetone kinase 2 homolog (S. cerevisiae) (DAK) from ORIGENE TECHNOLOGIESTP30172420 ugORIGENE TECHNOLOGIES
Mouse bone morphogenetic protein 4 (Bmp4). from ORIGENE TECHNOLOGIESTP72304410 ugORIGENE TECHNOLOGIES
EID2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4022511 kitORIGENE TECHNOLOGIES
Eid2b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5050831 kitORIGENE TECHNOLOGIES
EID2B Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30225110 ugORIGENE TECHNOLOGIES
EHMT2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4192001 kitORIGENE TECHNOLOGIES
Ehmt1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5050781 kitORIGENE TECHNOLOGIES
Ehmt2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5050791 kitORIGENE TECHNOLOGIES
EHMT2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31920010 ugORIGENE TECHNOLOGIES
Human myocyte enhancer factor 2A (MEF2A), transcript variant 1 from ORIGENE TECHNOLOGIESTP31283020 ugORIGENE TECHNOLOGIES
Human myocyte enhancer factor 2B (MEF2B) from ORIGENE TECHNOLOGIESTP32721420 ugORIGENE TECHNOLOGIES
Human myocyte enhancer factor 2C (MEF2C), transcript variant 1 from ORIGENE TECHNOLOGIESTP32058420 ugORIGENE TECHNOLOGIES
Human myocyte enhancer factor 2D (MEF2D) from ORIGENE TECHNOLOGIESTP30874820 ugORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS8070445x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS8094255x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS5073555x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS5187855x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS5297645x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS5357385x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS5367875x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS5378485x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS6175295x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS6189655x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma from ORIGENE TECHNOLOGIESCS6337795x5umORIGENE TECHNOLOGIES
Human Myometrium; Leiomyosarcoma, metastatic from ORIGENE TECHNOLOGIESCS7124995x5umORIGENE TECHNOLOGIES
Human Myometrium; Lipoleiomyoma of myometrium from ORIGENE TECHNOLOGIESCS5257675x5umORIGENE TECHNOLOGIES
Human Myometrium; Lipoleiomyoma of myometrium from ORIGENE TECHNOLOGIESCS5257685x5umORIGENE TECHNOLOGIES
 |< < 5005 5006 5007 5008 5009 5010 5011 5012 5013 > >| 第 5005/6274 页